The author discusses the Howard Hughes Medical Institute (HHMI) and its efforts to deal with the challenges in biomedical research. Topics discussed include HHMI's commitment to support basic research, advances from individuals working in relative obscurity, and increasing imbalance between clinical disease-specific research resources and fundamental discovery science.